Phibro Animal Health (PAHC) EBIT Margin (2012 - 2026)

Phibro Animal Health's EBIT Margin history runs 15 years deep, the most recent figure standing at 11.64% for Q1 2026.

• In Q1 2026, EBIT Margin rose 201.0% year-over-year to 11.64%; the TTM figure through Mar 2026 stood at 12.0% (up 400.0% YoY), while the FY2025 annual figure was 8.52%, up 328.0% from the prior year.
• EBIT Margin was 11.64% for Q1 2026 at Phibro Animal Health, down from 13.46% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 14.09% in Q3 2025 to a low of 0.31% in Q3 2023.
• Historically, EBIT Margin has averaged 8.19% across 5 years, with a median of 8.01% in 2022.
• The sharpest annual moves came in 2023 and 2025: EBIT Margin sank 620 bps in 2023, then surged 729 bps in 2025.
• A 5-year view of EBIT Margin shows it stood at 6.48% in 2022, then declined by 3 bps to 6.28% in 2023, then soared by 31 bps to 8.26% in 2024, then soared by 63 bps to 13.46% in 2025, then fell by 14 bps to 11.64% in 2026.
• The last three EBIT Margin figures came in at 11.64% (Q1 2026), 13.46% (Q4 2025), and 14.09% (Q3 2025), per Business Quant data.